
CDMO News
3PBIOVIAN and Eleva Partner to Advance Biologics Manufacturing with Moss-Based Technology
3PBIOVIAN and Eleva have formed a strategic alliance to advance the manufacturing of clinical-grade biologics, including Eleva’s Factor H (CPV-104) program. Under the agreement, 3PBIOVIAN, a contract development and manufacturing organisation (CDMO), will provide production capacity to support Eleva’s clinical